Blood Flow Path Reconstruction in Rectal Cancer
1 other identifier
observational
89
1 country
1
Brief Summary
A total of 89 patients with distal sigmoid and rectal cancer were referred for observation and underwent MS-CTA between June 2020 and March 2022. The distribution of the left colic artery (LCA) was classified, and the presence of the accessory middle colic artery (AMCA) was assessed. Blood flow paths were planned preoperatively based on the classification of LCA branches. High ligation was performed during standard radical surgery. Intraoperatively, particular care was taken to preserve the bifurcation of the ascending and descending branches of the LCA. The planned blood flow paths were then compared with the actual postoperative blood flow paths to validate the previously proposed mechanism.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 8, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 8, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2022
CompletedFirst Submitted
Initial submission to the registry
December 21, 2022
CompletedFirst Posted
Study publicly available on registry
January 6, 2023
CompletedSeptember 22, 2025
December 1, 2022
1.7 years
December 21, 2022
September 16, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Six pattens of blood flow and AMCA based on the preoperative observation
1 hour after the manual subtraction computed tomography angiography (MS-CTA) procedure
Interventions
no intervention
Eligibility Criteria
Patients with distal sigmoid colon or rectal cancer and they were received routine laparoscopic surgery.
You may qualify if:
- Clinical diagnosis of distal sigmoid colon or rectal cancer
- cTNM stage confirmed as I-III on MRI or CT
- Undergoing laparoscopic anterior resection (LAR)
You may not qualify if:
- Arterial phase scanning initiated too early
- Unclear anatomic structure on imaging
- No postoperative enhanced CT
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Shandong First Medical Universitylead
- Jinan Central Hospitalcollaborator
Study Sites (1)
Guoqin LIU
Jinan, Shandong, 250013, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director.Liu
Study Record Dates
First Submitted
December 21, 2022
First Posted
January 6, 2023
Study Start
June 8, 2020
Primary Completion
March 8, 2022
Study Completion
March 31, 2022
Last Updated
September 22, 2025
Record last verified: 2022-12
Data Sharing
- IPD Sharing
- Will not share
It will be available when our paper is accepted.